# GPT-5-mini Review

**Role:** External referee review
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-06T12:51:29.016771
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 19869 in / 5926 out
**Response SHA256:** e60540a2a7c4e3d5

---

Summary
This is an ambitious and policy-relevant paper: it studies how the recent wave of U.S. state consumer data-privacy laws affects technology-sector employment and business formation, using a staggered DiD design with heterogeneity-robust estimators and public state-level administrative data. The core finding — large negative effects for Software Publishers (NAICS 5112) but an approximately zero net effect for the broader Information Sector (NAICS 51) — is potentially important for policy debates about federal privacy legislation. The paper is carefully organized, shows awareness of the recent methodological literature on staggered adoption DiD, and attempts a number of robustness checks.

However, the paper is not yet ready for a top general-interest journal. There are important formatting, inferential, identification, measurement, and presentation issues that must be addressed before this manuscript could be considered for publication in AER/QJE/JPE/ReStud/AEJ:EP. Below I give a detailed, rigorous review organized around your requested checklist and sections. I cite specific sections, tables, and figures and provide constructive next steps.

1. FORMAT CHECK (required: flag all format issues)
- Length: The LaTeX source includes a long main text, many figures and tables, and an appendix. The manuscript as provided appears to be comfortably above the minimum 25 pages (I estimate ~30–45 pages including figures and tables, excluding references/appendix). Confirm final compiled page count and ensure main text (excluding references and online appendix) meets journal-specific page limits and formatting requirements (e.g., AER/QJE often expect shorter lengths or a succinct main text with a longer online appendix).
- References: The bibliography covers many relevant references (Acquisti et al. 2016; Callaway & Sant'Anna 2021; Goodman-Bacon 2021; Sun & Abraham 2021; Rambachan & Roth 2023; etc.). I discuss additional literature below (Section 4). Add a few missing methodological and empirical references (see Section 4).
- Prose: Major sections (Introduction, Institutional Background, Theory, Literature, Data, Empirical Strategy, Results, Robustness, Discussion, Conclusion) are written in paragraph form (good). Bullet lists are used only in the Data section to list NAICS codes (acceptable).
- Section depth: Most major sections (Intro, Institutional Background, Theory, Data, Empirical Strategy, Results, Discussion) contain multiple substantive paragraphs. Good. Some subsections (e.g., parts of Robustness) are briefer and could be expanded with more detail (see below).
- Figures: The LaTeX source refers to many figures with informative captions (Figures 1–9). I cannot view the actual plotted graphics here; based on captions the figures appear to show the necessary information (rollout timeline, raw trends, event studies, randomization inference histogram, heterogeneity plots, map). Ensure every figure in final submission:
  - shows axes with units and tick labels,
  - has readable fonts and legends at journal print size,
  - includes sample sizes or numbers of states underlying plotted means where relevant,
  - and has clear figure notes describing data source and smoothing (if any).
- Tables: All tables in the source display numeric estimates and standard errors; no placeholder entries remain. However: several table notes report missing values with "—" (e.g., Table 2 Panel B/C for placebo sectors). Do not use dashes to mean “not estimated”: explain why (estimator not run for placebo sector) and, when possible, provide alternative estimates or explicitly label cells as NA rather than using ambiguous dashes.

2. STATISTICAL METHODOLOGY (critical)
The paper makes a credible effort at rigorous inference, but there are important inferential limitations that must be addressed before publication.

a) Standard errors
- Satisfied: Every reported coefficient in tables has standard errors in parentheses. The authors report that they use state-clustered standard errors throughout (e.g., Empirical Strategy, Sec. 6; Tables 2, 4, etc.). Good.

b) Significance testing
- Satisfied: The paper reports p-values and stars in tables, and conducts permutation-based Fisher randomization inference. However, there are two important concerns:
  1. Small effective number of treated clusters: only eight states have effective dates within the 2015Q1–2024Q4 sample and contribute post-treatment variation (repeated throughout: Abstract, Introduction, Sec. 2, Sec. 4, Table notes). With only eight effectively treated states, asymptotic cluster-robust inference is fragile. The authors are partially aware of this and report Fisher RI (good), but they then sometimes rely on clustered SE p-values (e.g., TWFE Information effect: clustered p = 0.029 vs. RI p = 0.404, Table 2 and Table 6 notes). The discrepancy must be emphasized and explained fully in the main text and tables (not buried in notes).
  2. In several places the authors report TWFE asymptotic p-values despite arguing that TWFE is biased in staggered settings; this is confusing and could mislead readers.

c) Confidence intervals
- Partially satisfied: The paper reports standard errors and often shows shaded 95% bands in figures (Figure 2 and Figure 3 captions reference 95% CIs). However, the main result table (Table 2 Panel B: CS-DiD) reports ATTs and standard errors but does not display 95% confidence intervals explicitly. Please add 95% CIs for main estimates in the tables or show them in parentheses in addition to SEs.

d) Sample sizes
- Partially satisfied: Table 2 reports N for TWFE and notes suppression leads to unbalanced panels (Table 2 bottom rows and Table 1 summary). However:
  - For each reported estimator and each regression, the sample size (N observations and number of clusters/states used in that regression) must be reported clearly in the table (not only at the bottom). For CS-DiD and Sun–Abraham estimates, report the number of treated states/cohorts that actually have post-treatment observations and the number of never-treated states used as controls.
  - For the Software Publishers (NAICS 5112) result, report which treated states are present in that unbalanced sample (Table note mentions some smaller states suppressed). Transparency on which treated states contribute to the software-publisher ATT is essential.

e) DiD with staggered adoption
- PASS: The authors explicitly use Callaway & Sant'Anna (2021) with never-treated controls, which avoids the primary TWFE bias concerns (see Empirical Strategy, Sec. 6 and Table 2 Panel B). They also report Sun–Abraham and TWFE for comparison (good). However, some issues remain (see identification and robustness below):
  - The authors sometimes report TWFE estimates as suggestive evidence; I recommend clearly relegating TWFE to a robustness/diagnostic panel only and emphasizing CS-DiD (their preferred estimator) in the main text and abstract.
  - They should present cohort-specific ATT(g, t) estimates (or at least cohort-average ATTs) in an appendix table/figure so readers can see heterogeneity across cohorts (California vs. 2023 adopters vs. 2024 adopters). The existing event-study plot aggregates across cohorts; cohort-level estimates are essential to assess heterogeneity and to interpret why TWFE and CS-DiD differ.

f) RDD
- Not applicable: This manuscript does not use RDD. No RDD checks needed.

Conclusion on methodology: The paper implements appropriate heterogeneity-robust DiD estimators and takes steps toward valid inference (state clustering, Fisher RI). BUT the analysis is underpowered given only eight states with effective dates in the sample window; Randomization Inference shows the TWFE Information effect is not uncommon under permutations (RI p = 0.404, Table 6 / Fig. 5), and HonestDiD sensitivity analysis did not converge. The short-run nature of many post-treatment windows (most treated states have very few post quarters) further weakens causal claims. Therefore: the methodology, as implemented, is necessary but not sufficient for publication in a top general-interest journal in its current form. The paper is salvageable but requires substantial additional work (see Section 6 below). If the authors cannot materially strengthen power or present more convincing design-based inference for their main effects, the paper is not publishable in a top journal.

3. IDENTIFICATION STRATEGY (credibility, assumptions, robustness)
- Strategy: The staggered DiD design leveraging Callaway–Sant'Anna with never-treated controls is appropriate for staggered policy adoption (Sec. 6). Coding of treatment at the quarter of the effective date (with the “first full quarter” rule) is defensible and the authors test enacted-date sensitivity (Robustness, Sec. 8).
- Assumptions discussed: The paper explicitly discusses parallel trends and no-anticipation assumptions (Sec. 6). The event-study (Fig. 3) shows pre-treatment coefficients centered around zero for the main outcomes (claims in Results, Sec. 9).
- Concerns and recommended fixes:
  1. Small number of treated clusters and short post-treatment windows. Only 8 treated states provide post-treatment variation; many adopters (11 states) are “enacted-but-not-yet-effective” and counted as not-yet-treated in the sample while they have been legislatively enacted (multiple places: Abstract, Intro p.1–2, Data Sec. 5). This coding is defensible but creates power problems. Consider:
     - Extending the sample window if possible (if later quarters are available).
     - Obtaining longer post-treatment windows by shifting to monthly analysis (you already do BFS at monthly->quarterly; QCEW is quarterly but perhaps a longer endpoint exists).
     - Complement with alternative identification: e.g., synthetic control for California, or donor pool synthetic controls for other large states, or use state-level event-study with staggered timing but present cohort-specific ATTs (see earlier).
  2. Treatment endogeneity: Why do some states adopt privacy laws earlier than others? The paper briefly notes differences across states, but adoption could correlate with economic trends (e.g., states with larger tech sectors may be more likely to adopt, and that same sector may have idiosyncratic trends). The authors use state and quarter fixed effects and include state-time varying covariates (GDP, unemployment, political composition) in CS-DiD outcome model (Sec. 5). Still:
     - Provide formal tests for pre-treatment differential trends beyond visual inspection: show pre-treatment slopes and statistical tests (you report slope pretrend tests in Table 6 Panel C but give only p-values; present full pre-trend coefficients and CIs).
     - Provide placebo-event tests that push treatment earlier (timing placebo) and show whether effects appear prior to enactment/effective date (you mention timing placebos in Sec. 6 but show only limited randomization inference in Figure 5 / Table 6; expand).
  3. Heterogeneous treatment effects: The divergence between TWFE and CS-DiD suggests heterogeneity across cohorts (the authors note this). To assess economic importance:
     - Present cohort-specific ATT(g) estimates in a new figure/table (e.g., show ATT for California cohort separately).
     - Present the Goodman-Bacon decomposition if feasible for balanced samples or explain why not in more detail and provide alternative diagnostics (e.g., cohort-weighted average ATT accompanied by cohort weights).
  4. Mechanism verification: The interpretation that software publishing declines because it is data-intensive vs. computer system design gains because compliance demand increases is plausible but partly speculative:
     - Consider firm-level microdata (LEHD/Quarterly Workforce Indicators, ORBIS, Crunchbase, or state-level business registries) to track firm entry/exit or payroll-by-firm to test whether data-intensive firms exit and compliance firms expand within industries.
     - If firm-level data are infeasible, provide additional subsector evidence (e.g., differential effects by establishment size deciles — you already have establishment and wage results, which is good; expand on them).
- Bottom line: Identification is conceptually credible and the authors use state-of-the-art estimators. But due to limited treated clusters, short post-periods, and the potential endogeneity of adoption timing, the causal claims require tempering and additional robustness. As-is, the empirical strategy does not provide the level of causal certainty necessary for a top general-interest journal.

4. LITERATURE (missing references and BibTeX)
The paper cites most of the key staggered-DiD methodological references (Callaway & Sant'Anna 2021; Goodman-Bacon 2021; Sun & Abraham 2021; Rambachan & Roth 2023; de Chaisemartin & d’Haultfoeuille 2020; Athey & Imbens 2022). The privacy/regulation literature coverage is reasonable, but I recommend adding the following specific citations (methodological and empirical) for completeness and to strengthen positioning:

- For staggered DiD and inference with few treated clusters / randomization inference and design-based approaches:
  - Athey, Susan, and Guido W. Imbens. 2018. (seminal on design-based perspective; you cite Athey & Imbens 2022 but the 2018 design-based discussion is widely referenced)
  - Citations/bibtex:

  ```bibtex
  @article{AtheyImbens2018,
    author = {Athey, Susan and Imbens, Guido W.},
    title = {Design-based analysis in difference-in-differences settings with staggered adoption},
    journal = {Unpublished manuscript (available online)},
    year = {2018}
  }
  ```

  (If you prefer an alternative peer-reviewed reference, include Athey & Imbens 2022 already cited.)

- For economic effects of GDPR and other privacy regulation on firm outcomes (a few additional empirical references):
  - Cavallo et al. (2022) on GDPR effects on online advertising / consumption (if available).
  - Bourreau, de Streel, and Manach (2021) provide policy-oriented analyses of GDPR effects on markets (journal/working paper). Add to show engagement with policy debate.

  Example BibTeX for a GDPR firm-level effects paper (replace with exact details you choose to add):

  ```bibtex
  @article{Jia2021,
    author = {Jia, Jing and Jin, Guang and Wagman, Leonard},
    title = {The short-run effects of the General Data Protection Regulation on technology venture investment},
    journal = {Marketing Science},
    year = {2021},
    volume = {40},
    pages = {661--684}
  }
  ```

- For industry-location and regulatory sorting literature (complements Greenstone 2002; Kahn 2000):
  - Autor, Dorn, Hanson, and Song (2014) on geography of jobs and adjustment (for discussions of compositional changes and local labor market responses).
  - Example BibTeX:

  ```bibtex
  @article{Autor2014,
    author = {Autor, David and Dorn, David and Hanson, Gordon and Song, Jae},
    title = {Trade Adjustment: Worker-level Evidence},
    journal = {Quarterly Journal of Economics},
    year = {2014},
    volume = {129},
    pages = {1799--1860}
  }
  ```

Rationale: These additions will help position your work within the broader empirical literature on regulation-induced sorting and the literature on privacy regulation's economic effects. Please include concrete, directly relevant GDPR-era empirical papers (I listed Jia et al. 2021, which you already cite; add other high-quality working papers or published articles that study GDPR impacts on firm investment, ad markets, website traffic, entrepreneurship) and one or two design-based inference references focused on DiD with few treated clusters.

(You already cite many essential methodological works; the additions above fill a few gaps and improve framing.)

5. WRITING QUALITY (critical)
Overall the prose is solid, rigorous, and organized. That said, for a top journal the writing must be crisp, transparent about limitations, and readable to a broad audience. Specific points:

a) Prose vs. bullets
- Satisfied: Major sections are in paragraphs. The small number of bullets in the Data section (listing NAICS codes) is acceptable.

b) Narrative flow
- The introduction (Sec. 1) is well-constructed and hooks the reader with a clear empirical question and preview of results. The argument flows logically from motivation → method → evidence → policy implications. However:
  - The Intro repeatedly states that only 8 states contribute post-treatment variation; this point is crucial and should be highlighted earlier and more prominently in the abstract and opening paragraphs, as it substantially affects inference. The current abstract mentions 8 effective dates but could more clearly caveat the strength of causal inference given limited treated states.
  - After the main findings, the policy implications are discussed, but the caveats (power, dependence on California) must be given greater prominence in both the abstract and the concluding paragraphs.

c) Sentence quality
- Prose is generally crisp, albeit sometimes dense (e.g., long sentences in Institutional Background and Mechanisms). Trim some long sentences for readability. Put the key message at paragraph beginnings in several places (e.g., the Robustness section should start by summarizing what the robustness checks imply for causal credibility).

d) Accessibility
- The econometric choices (why CS-DiD vs. Sun–Abraham vs. TWFE) are explained but could be made more accessible with a short “cartoon” explanation in the Empirical Strategy section: a 2–3-sentence intuitive note on how TWFE can give misleading weights in staggered adoption and why CS-DiD fixes this by comparing treated cohorts only to never-treated states.
- Technical terms are mostly explained on first use, but add brief intuition for “doubly robust estimation” in the methods and for the implications of BLS disclosure suppression for NAICS 5112 (it is mentioned, but a short example would help).

e) Figures/tables
- Most captions are informative; ensure figure axes and legends are clear and include sample sizes. Make sure all tables are self-contained: add a sentence in table notes defining precisely what the dependent variable is (log average monthly employment), the exact sample (years, states), and the estimator used. For CS-DiD, explain in the table note that the estimator uses never-treated controls and how missing cells are handled.

6. CONSTRUCTIVE SUGGESTIONS (to make the paper publishable)
The paper shows promise. To make it more impactful and to pass the high methodological and exposition bar for top journals, consider the following substantive improvements.

A. Address inferential weakness due to small number of post-treatment states
- Primary option: Extend the sample period if more recent QCEW data are available (e.g., to 2025Q4) so that more treated states accumulate post-treatment quarters. The authors state many laws become effective in 2025–2026; waiting for more post-treatment data will materially improve power.
- Alternative designs if extending the sample is infeasible:
  - Cohort-specific analysis: present the ATT for each cohort (California, 2023 adopters, 2024 adopters). This will show whether the Software Publishers effect is mainly California-driven.
  - Synthetic control(s): for California (and perhaps for other large early adopters), present SCM or generalized synthetic control estimates at the state-industry level for NAICS 5112 to corroborate DiD results. SCM is especially helpful when a single large treated unit dominates identification.
  - Panel permutation / randomization inference with constrained permutations: the authors already do RI; expand it to test robustness to different permutation rules and show full permutation distributions for CS-DiD ATTs as well as TWFE.
  - Pre-analysis power calculations: include a short power calculation that shows the minimal detectable effect (MDE) given the number of treated states, average variance, and cluster correlation. This will help interpret null results.

B. More transparent reporting of which states contribute to each estimate
- For each main NAICS outcome (Information, Software Publishers, CS Design), provide a table listing for each treated state whether it appears in the industry-specific estimation (i.e., whether BLS suppression excludes that state-quarter), and how many post-treatment quarters they contribute. This will clarify whether, for example, the NAICS 5112 result is driven primarily by California and a few large states.

C. Cohort-level heterogeneity and mechanism tests
- Present cohort-by-cohort ATT(g,t) estimates (Appendix Figure/Table). If California dominates, be upfront and show its separate estimate.
- Firm-size heterogeneity: you already report establishment counts and wage effects, which is excellent. Expand on this:
  - Provide quantile estimates by establishment size (if available from QCEW: small, medium, large establishments).
  - Show entry vs. exit: compute net establishment formation rates pre/post for treated vs. control.
- Explore employment shares within NAICS 5112 by establishment size or by portions of the subsector that are likely data-intensive (if any more granular data exist).
- Firm-level data: if feasible, use microdata (LEHD/Quarterly Workforce Indicators, BDS or Census Longitudinal Business Database, or other sources) to track establishment exits and hires in data-intensive firms vs. others. This would strengthen causal mechanism claims.

D. Robustness and sensitivity
- HonestDiD: the paper attempts Rambachan & Roth but says it does not converge due to small cohorts. Explain more fully in the appendix why it fails (include diagnostic output, sample sizes, and describe whether reparameterizing the bound or using alternative pre-trend metrics helps).
- Show cohort-aggregated placebo results and placebo-onset tests (move timing placebo results into main robustness table).
- Show the Sun–Abraham and CS-DiD results with and without state-specific linear trends (as a robustness check), but discuss the interpretation (could soak up treatment effects).
- Address potential anticipatory behavior more formally: include leads up to e.g., e = −8 and show coefficients and CIs (your event study probably does this but make explicit).

E. Presentation and policy framing
- Tone down causal claims where power is weak (especially for aggregate Information Sector effect). Use language such as “we find suggestive evidence that…” when results are sensitive to estimator and inference method.
- Add a short policy sub-section that provides numerical magnitudes in context (e.g., 7.7% decline in NAICS 5112 — what does that imply in jobs lost nationally and relative to the sector’s baseline? Table 1 has mean employment; translate to levels).
- Clarify cost–benefit implications carefully: the composition effect raises distributional concerns but may not imply net welfare losses. Avoid overreaching claims.

7. OVERALL ASSESSMENT
- Key strengths
  - Timely, policy-relevant question with potential high impact.
  - Uses state-of-the-art staggered DiD estimators (Callaway–Sant'Anna), reports Sun–Abraham and TWFE as comparisons, and performs multiple robustness exercises (Fisher RI, placebo sectors).
  - Thoughtful theoretical framework motivating compositional/ sorting hypothesis.
  - Use of establishment and wage outcomes to probe mechanisms is a strong point.

- Critical weaknesses
  - Statistical power and inference: only eight states provide post-treatment variation; randomization inference produces weak evidence for the Information Sector effect and HonestDiD did not converge. This undermines the strength of the causal claims.
  - Dependence on California and early adopter cohorts: cohort heterogeneity is visible; the paper must demonstrate results are not driven by one large unit or, if they are, present that explicitly and contextualize.
  - Measurement: NAICS codes are imperfect proxies for data intensity; the claim that NAICS 5112 is “data-intensive” is plausible but needs more substantiation or micro-level evidence.
  - Presentation: some important caveats are buried in notes; these should be elevated to the main text, especially the limited number of treated clusters and the implications for inference.

- Specific suggestions for improvement (recap)
  1. Extend sample or delay submission until more post-treatment quarters are available, or complement with state-level synthetic control estimates (California at minimum).
  2. Report cohort-specific ATTs and show which states contribute to each industry-specific regression; provide an MDE/power calculation.
  3. Improve robustness/inference: report permutation distributions for CS-DiD; show HonestDiD diagnostics or justify why alternative sensitivity methods are infeasible.
  4. Strengthen mechanism evidence using establishment-size heterogeneity, firm-level data, or industry-specific proxies for data intensity.
  5. Make the limitations and uncertainty much more prominent in abstract, intro, and conclusion; avoid overstating causal certainty.

Decision (required)
Given the substantive importance of the question, the use of modern methods, but the significant inferential limitations (small number of treated states contributing post-treatment, sensitivity of the aggregate result to estimator and inference method, dependence on California), I recommend a major revision. The paper is promising and could be publishable in a top journal after the authors address the inferential and robustness concerns, add clearer cohort-level evidence, and strengthen mechanism tests.

DECISION: MAJOR REVISION